Farms.com Home   News

Early Cross Fostering Reduces Potential for Greasy Pig Disease

The Canada West Swine Health Intelligence Network is advising pork producers that early cross fostering of newborn piglets can help reduce their potential exposure to the bacteria responsible for Greasy Pig Disease. Greasy Pig Disease, a bacterial infection that affects the skin of the pig, is one of the infections identified as part of the Canada West Swine Health Intelligence Network's swine disease surveillance report for the first quarter of  2021.

The primary cause of the disease is Staphylococcus hyicus, which is known to colonize the skin of pigs without causing infection. CWSHIN Manager Dr. Jette Christensen says the infection came up during the quarterly conference call with veterinarians.

Clip-Dr. Jette Christensen-Canada West Swine Health Intelligence Network:

A few practices reported or could mention that they seem to see an uptick in Greasy Pig, so Staphylococcus hyicus infection. It wasn't noticeable in any data or anything. It was just a discussion point but it was noticeable that a few practices had seen the same thing.

It was also mentioned that maybe we should think about that teeth clipping is not done in about 70 percent of the sow herds anymore. So, when the competition for teats in the early ages starts and  there's fighting over that, there might be a few more facial lesions on the piglets and they can in turn become infected with Staphylococcus and then they show up as greasy pigs.

The take home message here is really that, if you do cross fostering, make sure you do it as early as possible to limit the competition and fighting in the litters.

Source : Farmscape

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.